In Conclusion, LPCAT1 overexpression in CRPC cells drives tumor progression, both via PAF-mediated enhancement of tumor motility and LPCAT1 nuclear-localization-mediated histone H4 O-palmitoylation in an androgen-dependent but AR-independent fashion, ultimately enhancing mRNA synthesis and cell proliferation. The gene discussed is AR; the disease is neoplasm.